| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 177,355 | 243,909 | 297,223 | | Cost of Revenue | 12,630 | 17,930 | 18,926 | | | Gross Profit | 164,726 | 225,979 | 278,297 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 2,650 | 2,889 | 2,911 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 162,075 | 223,090 | 275,387 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (890,167) | (328,722) |
-
| | Earnings Before Interest And Taxes | 162,075 | 201,568 | 197,803 | | Interest Expense | 182 | 3,356 | 4,584 | | Income Before Tax | 161,893 | 198,212 | 193,219 | | Income Tax Expense |
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (728,274) | (108,988) | 270,803 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (728,274) | (108,988) | 270,803 | | Preferred Stock And Other Adjustments | (18,254) | (46,218) | (44,998) | | | Net Income Applicable To Common Shares | ($746,527) | ($155,206) | $225,805 |
|
1.48% Nasdaq 
0.06 (0.56%) 
Income Statement
